Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 22;107(25):11489-94.
doi: 10.1073/pnas.1003988107. Epub 2010 Jun 7.

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

April E Price  1 , Hong-Erh Liang, Brandon M Sullivan, R Lee Reinhardt, Chris J Eisley, David J Erle, Richard M Locksley
Affiliations

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

April E Price et al. Proc Natl Acad Sci U S A. .

Abstract

Type 2 immunity is a stereotyped host response to allergens and parasitic helminths that is sustained in large part by the cytokines IL-4 and IL-13. Recent advances have called attention to the contributions by innate cells in initiating adaptive immunity, including a novel lineage-negative population of cells that secretes IL-13 and IL-5 in response to the epithelial cytokines IL-25 and IL-33. Here, we use IL-4 and IL-13 reporter mice to track lineage-negative innate cells that arise during type 2 immunity or in response to IL-25 and IL-33 in vivo. Unexpectedly, lineage-negative IL-25 (and IL-33) responsive cells are widely distributed in tissues of the mouse and are particularly prevalent in mesenteric lymph nodes, spleen, and liver. These cells expand robustly in response to exogenous IL-25 or IL-33 and after infection with the helminth Nippostrongylus brasiliensis, and they are the major innate IL-13-expressing cells under these conditions. Activation of these cells using IL-25 is sufficient for worm clearance, even in the absence of adaptive immunity. Widely dispersed innate type 2 helper cells, which we designate Ih2 cells, play an integral role in type 2 immune responses.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Lineage-negative cells are systemically distributed at rest and possess a unique surface phenotype. (A) Gating scheme for lineage-negative cells in 4get mice. Example shown is resting liver. Box denotes lineage-negative gate. Numbers denote percentage of boxed cells of total. (B) Staining with a lineage-marker antibody mixture (CD3ε, Ly-6G/Ly-6C, CD11b, CD45R, and TER-119). Eosinophils are used as a positive control, whereas basophils are used as a negative control. (C) Surface-marker antibody staining (black lines) compared with isotype control (gray) on lineage-negative cells from resting liver. (D) Numbers of lineage-negative cells in organs and tissues at rest. Experiment was independently repeated three times, and data were combined for graph (n = 3–14 mice per group). (E) Gating of lineage-negative cells in 4get mice compared with 4get × common-γ−/− mouse liver. Lineage-negative cells collect in side-scatter (SSC)-lo, CD49b-negative gate. Numbers are percentages of total non-CD4 GFP-positive cells.
Fig. 2.
Fig. 2.
Lineage-negative cells increase in number after IL-25 administration and during infection. (A) Numbers of lineage-negative cells and eosinophils in designated organs after four daily doses of 500 ng IL-25 or IL-33. (B) Numbers of lineage-negative cells after infection with N. brasiliensis. Experiments were repeated three times, and data were compiled for graphs (n = 3–14 mice per group). Bars are means with SEM.
Fig. 3.
Fig. 3.
Lineage-negative cells are a distinct Th2-associated cell type. (A) Relative gene expression in Th2 cells (two samples), lineage-negative cells (three samples), and basophils (three samples) isolated from N. brasiliensis-infected mice. Heat map shows log2 (sample intensity/mean intensity for all eight samples) for all microarray probes with differential expression (false discovery rate (FDR) < 0.05) in any pairwise comparison between cell types. (B) Grouping of microarray probes based on their expression in lineage-negative cells, Th2 cells, and basophils. Signal intensity cutoff of 28 is ~23-fold higher than the median signal obtained with randomized negative-control probes. *, Itga4, integrin alpha 4; Jag1, Jagged 1; IL9R, IL-9 receptor; IL1R1, IL-1 receptor type 1; Ptger3, prostaglandin E receptor 3; CCR3, chemokine receptor 3; Btk, Bruton agammaglobulinemia tyrosine kinase; Gata3, GATA binding protein 3; Ikzf3, IKAROS family zince finger 3 (Aiolos); IL2ra, IL-2 receptor alpha chain; Rgs18, regulator of G protein signaling 18; Tph1, tryptophan hydrolase 1; Chdh, choline dehydrogenase; Stat-6, signal transducer and activator of transcription 6 (C). Diagram showing the numbers of probes in each of the seven groups listed in B.
Fig. 4.
Fig. 4.
Lineage-negative cells are major innate IL-13–expressing cells. (A) Gating of YFP+ lineage-negative cells from YetCre13 Rosa-YFP amplifier mice. Example shown is of liver after administration of IL-25. Gates and percentages are as in Fig. 1. (B) Numbers of YFP+ lineage-negative cells after IL-25 administration. Experiment was repeated two times, and results were compiled (n = 2–3 mice per group). Bars are means with SEM. (C) Time course showing YFP+ lineage-negative cells from designated organs during infection with N. brasiliensis. Experiment was repeated two times, and results were compiled (n = 3–5 mice per group). Bars are means with SEM. (D) Gating of non-CD4+ YFP+ cells showing percentages of mast cells (c-kithiIgE+) and lineage-negative (c-kitloIgE−) cells in multiple organs after IL-25 administration (Upper) or after infection with N. brasiliensis (Lower).
Fig. 5.
Fig. 5.
Lineage-negative cells contribute to eosinophilia and mediate IL-25–dependent worm clearance. (A) Gating of GFP+CD4- cells in IL-25–treated 4get YetCre13-Rosa-DTA deleter mice or 4get YetCre13 littermates. Percentages shown are eosinophils (SSChiCD49blo), basophils (SSCloCD49b+), and lineage-negative cells (SSCloCD49b−). (B) Numbers of lineage-negative cells and eosinophils in multiple organs in 4get YetCre13-DTA deleter mice or 4get YetCre13 controls after administration of IL-25. Experiment was repeated two times, and results were compiled (n = 3–5 mice per group). Bars denote means with SEM. (C) Rag2−/−, common-γ−/− × Rag2−/−, or common-γ−/− × Rag2−/− mice adoptively transferred with 500,000 lineage-negative cells 2 d previously were infected with N. brasiliensis. Five mice from each group received IL-25 on days 0–4. Worm counts from the small intestine and numbers of eosinophils (SSChiCD11b+Siglec-F+) were quantified on day 5. Experiment was repeated two times, and a representative experiment is shown.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Finkelman FD, et al. Interleukin-4- and interleukin-13–mediated host protection against intestinal nematode parasites. Immunol Rev. 2004;201:139–155. - PubMed
    1. Anthony RM, Rutitzky LI, Urban JF, Jr., Stadecker MJ, Gause WC. Protective immune mechanisms in helminth infection. Nat Rev Immunol. 2007;7:975–987. - PMC - PubMed
    1. Reinhardt RL, Liang HE, Locksley RM. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol. 2009;10:385–393. - PMC - PubMed
    1. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity. 2004;20:267–277. - PubMed
    1. Gessner A, Mohrs K, Mohrs M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol. 2005;174:1063–1072. - PubMed

Publication types